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Abstract: Fusarium fungi are common plant pathogens causing several plant diseases. The presence
of these molds in plants exposes crops to toxic secondary metabolites called Fusarium mycotoxins.
The most studied Fusarium mycotoxins include fumonisins, zearalenone, and trichothecenes. Studies
have highlighted the economic impact of mycotoxins produced by Fusarium. These arrays of toxins
have been implicated as the causal agents of wide varieties of toxic health effects in humans and
animals ranging from acute to chronic. Global surveillance of Fusarium mycotoxins has recorded
significant progress in its control; however, little attention has been paid to Fusarium mycotoxins in
sub-Saharan Africa, thus translating to limited occurrence data. In addition, legislative regulation is
virtually non-existent. The emergence of modified Fusarium mycotoxins, which may contribute to
additional toxic effects, worsens an already precarious situation. This review highlights the status
of Fusarium mycotoxins in sub-Saharan Africa, the possible food processing mitigation strategies,
as well as future perspectives.
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1. Introduction
Fusarium is one of the most important filamentous pathogenic mold genera widely distributed
around the world. These molds are often referred to as field or soil fungi because of their great
pathogenic potential, thus causing a wide range of plant diseases called fusariosis, such as vascular
wilts, seedling blights, rots, and cankers [1,2]. Fusariosis causes enormous economic losses to crops
thereby affecting trade and marketing worldwide. This is evidenced by the estimated crop yield
reduction between 10% and 40% reported by Bottalico and Perrone [3]. In the USA, the genus Fusarium
has been estimated to cause losses worth 2900 million US dollars annually for wheat and barley [4].
In addition to their pathogenicity to plants, Fusarium species are capable of synthesizing a wide
range of secondary metabolites of diverse structures and actions. Species such as F. verticillioides and
F. graminearum, each have the ability to synthesize more than one metabolite. Fusarium metabolites
of economic importance include fumonisins, zearalenone, and trichothecenes. Their importance is
partly ascribed to the presence of some base-line scientific data as well as documented significant
impact on public health and animal productivity across several countries. These toxins have been
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implicated as causing several devastating diseases in humans and animals ranging from acute to
chronic with carcinogenic, estrogenic, mutagenic, hepatotoxic, teratogenic, hemorrhagic, neurotoxic,
and/or immunosuppressive effects [5]. They may co-exist in feeds, foods, and processed food products
because some fungi have the ability to produce more than one mycotoxin, and/or more than one
fungi species may colonize a substrate. Thus, an intrinsic quality is the exhibition of a synergistic,
additive, and/or antagonist health effect on the human or animal host [6]. In addition to their
harmful significances to health, mycotoxins are major food contaminants affecting global food security,
especially in the developing countries. The Food and Agriculture Organization (FAO) of the United
Nations estimates that about 25% of world food crops are contaminated with mycotoxins [7]. Cases of
food destruction owing to high mycotoxin levels leading to losses of millions of dollars have also been
reported [8,9]. Wu [10] reported an estimated annual economic loss of between 1 and 46 million US
dollars as a result of fumonisin contamination in animal feed, leading to market and animal life losses
in the United States. Losses resulting from all mycotoxin-related issues in agriculture in the United
States have been estimated to be as high as 1.4 billion dollars annually [11].
The emergence and occurrence of new Fusarium metabolites in food crops and products is
of great concern. The occurrences of emerging mycotoxins produced by Fusarium spp., such as
fusaproliferin, beauvericin, enniatins, and moniliformin have been reported in food crops representing
an important problem in some parts of the world [12,13]. The risk of human and animal exposure
to these mycotoxins has led to continuing elucidation of chemical structures and possible further
alteration of a Fusarium toxin's structure in crops and food products. Gareis et al. [14] observed
some cases of mycotoxicosis symptoms in animals which did not correlate with the corresponding
low-mycotoxin-contaminated feeds they were consuming. The elevated toxicity was ascribed to
undetected conjugated forms of mycotoxins that were possibly hydrolyzed into the free toxins in the
digestive tract of the animals. This is supported by the recent in vitro study of Gratz et al. [15] and
Ajandouz et al. [16] which revealed the potential hydrolyses of conjugated mycotoxins into parent
mycotoxins by the microbiota in the human gut. These undetected conjugated mycotoxins, referred
to as modified mycotoxins, may be matrix-associated; biologically modified by plants, animals, or
fungi; or chemically modified by thermal or non-thermal processing [17]. Recently, much attention
has been channeled to modified mycotoxins, especially in the developed countries. Several studies
have proven the existence of modified mycotoxins in crops and food products [18–28]. Conversely,
the limited existence of toxicological data on modified mycotoxins has contributed to the difficulty in
ascertaining their toxicity effects.
Although Fusarium mycotoxins have been associated with temperate climate, recent trends in
climatic change seem to have exposed the tropics to these toxins. Magan et al. [29], and Paterson
and Lima [30] emphasised the importance of climate in fungal colonization, as well as mycotoxin
contamination of foods and food products. Unfortunately, sub-Saharan Africa (SSA) has been reported
as a region of higher vulnerability to the impact of global climate change because of its sole dependence
on the weather and climate variables for agricultural production [31]. SSA is envisaged to become 5%
to 8% more arid and semi-arid, which perhaps will cause an increase in drought, and thus may lead to
increased crop stress and possibly mycotoxin contamination [32]. Tirado et al. [33] highlighted the
correlation between fumonisin occurrence and drought stress, as observed in maize planted during the
dry season in South and Eastern Africa. The trend of increase in fumonisin production in dry weather
was also reported by Munkvold and Desjardins [34].
Another possible route of exposure to Fusarium mycotoxins in SSA is through trade. Fungi can
easily spread from one area to another, and considering that there are no strict regulations and control
systems concerning mycotoxins in this region, SSA often times is exposed to contaminated foods and
products through global trade. Studies have reported a high incidence of Fusarium mycotoxins in
crops and food products in SSA [35–40]. A Biomin survey on the global mycotoxin threat also reported
high incidences of zearalenone (91%) and fumonisins (88%) in a majority of samples from Africa [41].
Despite the increasing concern on Fusarium mycotoxins and their modified forms worldwide, SSA
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has placed little importance on the occurrence and detection of these mycotoxins in crops and
food products, as well as their possible deleterious effects. Perhaps this could be as a result of
the non-availability of analytical facilities and the prevalence of food insecurity in the region. Another
school of thought is probably due to the special attention accorded to only Aspergillus mycotoxins
(especially aflatoxins) in the region, thereby neglecting other toxins. Notably, there is an absence
of regulations governing the control of Fusarium mycotoxins in SSA, thus subjecting the region to
strictly depend on maximum levels in regulations and guidelines of the European Union (EU) and the
Codex Alimentarius Commission (CAC) on Fusarium mycotoxins without putting into considerations
the feeding habits, food security status, occurrence levels in the region, and the genetic/hereditary
dispositions (genetic and environmental interactions) of the people that make up the region.
The absence of regulation is thus attributed to the lack of sufficient scientific data (occurrence, exposure,
and toxicological) and the socio-economic factors, such as public ignorance, hunger (as well as hidden
hunger), as well as political and economic instability. It is noteworthy to mention that only a few
of the countries in SSA have food control administrative systems that are functional. In most cases,
the weak regulatory bodies are led (most often by political appointees) most times by personnel and
stakeholders with minimal background knowledge about food toxins. The organization of academic
conferences and workshops have not yielded many anticipated results. A good starting point will be
the enhancement of knowledge and awareness. The availability of resource materials on Fusarium
mycotoxins in public domain, setting up promotions, and the establishment of integrated driven
interventions by government and stakeholders will definitely help to control these toxins. We propose
a shift in action through the establishment of country or regional hub reference testing laboratories.
This will go a long way in harmonizing efforts within countries while promoting a free flow of food
products. Although proactive legal procedures on Fusarium mycotoxin control will certainly increase
the burden of hunger with far reaching consequences, setting up Fusarium mycotoxins regulations
in SSA would be a guiding pillar, principle, and requirement for food safety, and a mechanism to
strengthen food control systems in the region.
This review focuses on the occurrence of Fusarium mycotoxins and their modified forms in SSA.
In addition, the authors provide an overview of food processing control strategies regarding Fusarium
mycotoxins, as well as future perspectives.
2. Occurrence of Fusarium Mycotoxins in Sub-Saharan Africa
The occurrence of Fusarium mycotoxins in agricultural products and its processed foods is of
great concern because of its toxic effects in humans and animals. Global occurrence data on Fusarium
mycotoxins have been reviewed [42–44], especially on the major mycotoxins (fumonisins, zearalenone,
and trichothecenes) and their possible health effects [45,46]. Conversely, it is of concern that, of all the
Fusarium mycotoxins existing, fumonisins are the only most studied in SSA, thus neglecting others and
placing SSA as the least studied with respect to Fusarium mycotoxins research, irrespective of climatic
change, food insecurity, poor prevention, and control strategies, and mycotoxin-poisoning problems
ravaging in this region. Additionally, it is worth mentioning that most of the studies on Fusarium
mycotoxins reported for the region were carried out in laboratories in the developed countries, thus
buttressing a lack of infrastructural facilities required to conduct such studies in SSA. Other issues
include the insufficient or lack of adequately trained personnel, as well as limited research investments
in terms of funding for SSA research centers and academic institutions. As much as there is a need to
reduce hunger within SSA (most especially in the resource poor communities), issues of food safety as
regards Fusarium mycotoxin occurrence in foods and food products should be considered paramount.
2.1. Fumonisins
Fumonisins (FBs) were first described in South Africa by Bezuidenhout et al. [47]. About 28
FB analogs have been characterized and are classified into four main groups (A, B, C, and P series),
with those belonging to the B series (FB1, FB2, and FB3) being the most abundant and of toxicological
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importance. Each FB in the B-series has a linear 20-carbon backbone with methyl, hydroxyl, and
tricarboxylic acid moieties at various positions along the backbone. FB compounds are produced by a
large array of Fusarium species, such as F. verticillioides and F. proliferatum. However, the production
of FB by Alternaria alternataf. sp. lycopersici and Aspergillus niger has also been reported [48,49].
Ingestion of FB has been associated with several human and animal ailments worldwide because of
their hepatotoxicity, nephrotoxicity, neurotoxicity, immune stimulation, and immune suppression,
causing several developmental abnormalities, and liver and kidney malfunctions [50–53]. Human
epidemiological studies have revealed a possible link of the consumption of FB-contaminated maize
(corn) with esophageal cancer in South Africa, China, Northeastern Italy, and the southeast of
the United States [50,54–56]. Cases of human abdominal pains and diarrhea were reported in
India, resulting from consumption of moldy maize or sorghum containing high levels of FB [57].
Simultaneously, there is an assumption of a possible increase in the risk of neural tube defects because
of the human maternal exposure to FB during the early stages of pregnancy [58]. Recently, the
International Agency for Research on Cancer (IARC) has reported the possible association between
fumonisin and stunting in children [59]. Cases of animal diseases as a result of FB have also been
reported [51,60–65].
The occurrence of FBs has been reported in several cereals, legume crops, spices, and food products
all over the world. Maize and its products remain the most contaminated because of the susceptibility
of the maize crop to FB-producing fungi. In SSA, maize serves as a major cereal consumed on a daily
basis by most of the population [38]. It is estimated that the average daily consumption rate of maize
per adult is as high as 500 g. Occurrence data in SSA reveal high incidences and high levels of FB
contamination of staple foods, especially maize (Table 1), which suggest that humans and animals in
this region may be highly exposed to toxic effects unleashed by FB. In spite of the high occurrences
and high levels of FB contamination and the fact that FB was first identified and characterized
in South Africa [47], there remains a huge gap in research, leading to inadequate occurrence and
toxicology data, and a lack of regulatory guidelines governing the control of this mycotoxin in SSA.
Of the 49 countries in SSA, only a few have data on the occurrence of FB contamination in crops and
food products (Table 1). However, because of the limited nature of the occurrence data reported so
far, not a single country has established FB regulatory limits. SSA still depends on the recommended
maximum levels set by the EU and the US Food and Drug Administration (FDA).
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Table 1. Occurrence and contamination levels of fumonisins in food crops and products in sub-Saharan Africa since the year 2000.
Country Commodity Toxin Type No of Sample Sample Preparation Technique % Positive Range (µg/kg) Reference
Botswana Sorghum malt FB1 46 SPE (SAX) HPLC 6.5 47–1316 [66]
Burkina Faso
Maize FB1 + FB2 124 NA HPLC 100 10–16,040 [67]
Maize FB1 26 NA HPLC/ESI-MS/MS 81 22.5–1343 [68]
Maize FB2 26 NA HPLC/ESI-MS/MS 69 11.3–589 [68]
Feed FB3 26 NA HPLC/ESI-MS/MS 46 23.2–274 [68]
Feed FB1 4 NA HPLC/ESI-MS/MS 75 578–3390 [68]
Feed FB2 4 NA HPLC/ESI-MS/MS 75 186–1235 [68]
Feed FB3 4 NA HPLC/ESI-MS/MS 75 70.0–362 [68]
Others FB1 30 NA HPLC/ESI-MS/MS 4 73.8 (median) [68]
Others FB2 30 NA HPLC/ESI-MS/MS 4 28.2 (median) [68]
Cameroon
Maize FB1 40 SPE(SAX) HPLC 65 37–24,225 [69]
Maize FB 165 SPE (amino) UPLC-MS/MS 74 20–5412 [40]
Maize FB 18 NA ELISA 88.9 nd–26,000 [70]
Peanut FB1 16 SPE (SAX) HPLC 18.8 25–1498 [69]
Bean FB1 15 SPE (SAX) HPLC 20 28–1351 [69]
Soybeans FB1 5 SPE (SAX) HPLC 40 25–365 [69]
Sorghum beer FB1 120 SPE (C18) ELISA 87.5 0–340 µg/L [71]
Maize FB1 37 NA LC-MS/MS 100 2–2313 [72]
Groundnut FB1 35 NA LC-MS/MS 51 0.4–10 [72]
Soybean FB1 10 NA LC-MS/MS 100 38–69 [72]
Maize beer FB1 14 NA LC-MS/MS 100 15–741 [72]
Groundnut soup FB1 15 NA LC-MS/MS 73 0.6–17 [72]
Kuru-Kuru FB1 6 NA LC-MS/MS 100 2–4.3 [72]
Dagwa FB1 8 NA LC-MS/MS 100 47–132 [72]
Maize FB2 37 NA LC-MS/MS 97 7–572 [72]
Groundnut FB2 35 NA LC-MS/MS 34 0.4–4 [72]
Soybean FB2 10 NA LC-MS/MS 100 7–19 [72]
Maize beer FB2 14 NA LC-MS/MS 100 0.6–127 [72]
Groundnut soup FB2 15 NA LC-MS/MS 33 <LOQ–6 [72]
Dagwa FB2 8 NA LC-MS/MS 100 15–37 [72]
Maize FB3 37 NA LC-MS/MS 95 <LOQ–157 [72]
Groundnut FB3 35 NA LC-MS/MS 43 <LOQ–5 [72]
Soybean FB3 10 NA LC-MS/MS 100 2.3–14 [72]
Maize beer FB3 14 NA LC-MS/MS 100 0.7–100 [72]
Groundnut soup FB3 15 NA LC-MS/MS 7 1.88 (mean) [72]
Kuru-Kuru FB3 6 NA LC-MS/MS 33 3.4–4.2 [72]
Dagwa FB3 8 NA LC-MS/MS 88 <LOQ–11 [72]
Maize FB6 37 NA LC-MS/MS 27 1036–4368 [72]
Maize beer FB6 14 NA LC-MS/MS 7 76.13 (mean) [72]
Groundnut soup FB6 15 NA LC-MS/MS 13 172–229 [72]
Toxins 2017, 9, 19 6 of 36
Table 1. Cont.
Country Commodity Toxin Type No of Sample Sample Preparation Technique % Positive Range (µg/kg) Reference
Côte d’Ivoire Corn FB1 10 NA ELISA 100 300–1500 [73]Peanut FB1 10 NA ELISA 70 <300–6000 [73]
Democratic Republic
of Congo
Maize FB 40 SPE (SAX), IAC TLC, HPLC 100 17.5–6258 [74]
Bean FB 30 SPE (SAX), IAC TLC, HPLC 83.3 3.2–321 [74]
Ethiopia
Sorghum FB 39 NA ELISA 7.7 1370–2117 [75]
Maize FB 17 NA ELISA 23.5 300–2400 [76]
Sorghum FB1 70 NA HPLC/ESI-MS/MS 14.3 nd–30.1 [77]
Sorghum FB2 70 NA HPLC/ESI-MS/MS 8.57 nd–8.4 [77]
Sorghum FB3 70 NA HPLC/ESI-MS/MS 1.43 nd–2.5 [77]
Millet FB1 34 NA HPLC/ESI-MS/MS 45.5 nd–49.2 [77]
Millet FB2 34 NA HPLC/ESI-MS/MS 27.3 nd–16.1 [77]
Millet FB3 34 NA HPLC/ESI-MS/MS 3.44 nd–6.3 [77]
Ghana
Maize FB 15 SPE (SAX) HPLC 100 70–52,670 [78]
Maize FB 75 SPE (SAX) HPLC 90.7 11–2500 [79]
Kenkey FB 75 SPE (SAX) HPLC 73.3 15–1000 [79]
Kenya Maize beer FB 61 NA QuickTox Kit 9.8 280–4000 [80]Kenyan Lager Beers FB1 75 SPE (C18) ELISA 72 0–0.78 µg/L [81]
Malawi Maize FB 90 NA HPLC/ESI-MS/MS 90 nd–6475 [82]Maize beer FB 9 SPE (C18), MultiSep UPLC-MS/MS 100 1898 (mean) [83]
Mozambique
Maize FB1 13 NA HPLC/ESI-MS/MS 92.3 159–7615 [68]
Maize FB2 13 NA HPLC/ESI-MS/MS 92.3 27.7–3061 [68]
Maize FB3 13 NA HPLC/ESI-MS/MS 85 26.6–777 [68]
Feed FB1 10 NA HPLC/ESI-MS/MS 70 810–20,579 [68]
Feed FB2 10 NA HPLC/ESI-MS/MS 80 13.5–7088 [68]
Feed FB3 10 NA HPLC/ESI-MS/MS 70 94.3–2264 [68]
Others FB1 7 NA HPLC/ESI-MS/MS 43 273–45,450 [68]
Others FB2 7 NA HPLC/ESI-MS/MS 57 11.5–15,254 [68]
Others FB3 7 NA HPLC/ESI-MS/MS 43 74.8–5115 [68]
Nigeria
Maize FB1 70 NA HPLC/ESI-MS/MS 92.9 1.8–10,447 [39]
Maize FB2 70 NA HPLC/ESI-MS/MS 92.9 12.8–3455 [39]
Maize FB3 70 NA HPLC/ESI-MS/MS 92.9 6.4–720 [39]
Maize FB1 182 NA LC-MS/MS 73 10–760 [84]
Maize snack FB 8 NA HPLC/ESI-MS/MS 100 4.8–339 [85]
Groundnut-Maize
snack FB 2 NA HPLC/ESI-MS/MS 100 12.5–130 [85]
Maize FB1 103 SPE (SAX) HPLC 78.6 70–1780 [86]
Maize FB2 103 SPE (SAX) HPLC 66 53–230 [86]
Maize FB1 108 NA HPLC 50.9 65–1800 [87]
Maize ∑FB 136 SPE (C18), MultiSep LC-MS/MS 65 32–8508 [88]
Sorghum ∑FB 110 SPE (C18), MultiSep LC-MS/MS 8 45–180 [88]
Millet ∑FB 87 SPE (C18), MultiSep LC-MS/MS 14 74–22,064 [88]
Ogi ∑FB 30 SPE (C18), MultiSep LC-MS/MS 93 125–3557 [88]
Rice FB1 21 NA HPLC 14.3 0.4–4.4 [89]
Rice FB2 21 NA HPLC 4.8 132.5 (mean) [89]
Poultry feed FB1 58 NA LC/ESI–MS/MS 83 31–2733 [90]
Poultry feed FB2 58 NA LC/ESI–MS/MS 81 51–1130 [90]
Poultry feed FB3 58 NA LC/ESI–MS/MS 76 37–369 [90]
Poultry feed FB4 58 NA LC/ESI–MS/MS 67 18–115 [90]
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Table 1. Cont.
Country Commodity Toxin Type No of Sample Sample Preparation Technique % Positive Range (µg/kg) Reference
Republic of Benin
Maize FB 36 IAC fluorometer 100 600–2400 [91]
Maize FB 48 IAC fluorometer NA nd–12,000 [92]
Cassava flour FB1 4 SPE (amino) UPLC-MS/MS 100 4–24 [93]
Maize FB1 4 SPE (amino) UPLC-MS/MS 100 51–836 [93]
Maize FB2 4 SPE (amino) UPLC-MS/MS 100 5–221 [93]
Maize FB3 4 SPE (amino) UPLC-MS/MS 100 <LOQ–375 [93]
Maize FB1 54 IAC LC-MS/MS 100 56–14,990 [38]
Maize FB2 54 IAC LC-MS/MS 100 38–6444 [38]
South Africa
Maize FB 40 SPE (SAX) HPLC 100 64–1035 [37]
Maize FB1 54 SPE (SAX) HPLC 87 101–53,863 [94]
Maize FB1 96 SPE (SAX) HPLC 38 100–22,200 [95]
Maize porridge FB1 47 SPE (SAX) HPLC 74 0.2–20 [94]
Compound feeds FB 92 SPE (SAX) HPLC 88 104–2999 [96]
Cooked maize FB1 28 SPE (SAX) HPLC 29 100–400 [95]
Tanzania
Maize FB1 + FB2 120 SPE (SAX) HPLC 52 61–11,048 [97]
Maize FB1 60 NA UHPLC/TOFMS 73.33 16–18,184 [98]
Maize FB2 60 NA UHPLC/TOFMS 48.33 178–38,217 [98]
Zambia Maize FB 114 NA ELISA 100 33,500–192,000 [99]
Zimbabwe
Maize FB1 95 SPE (amino) LC-MS/MS 95 nd–1106 [100]
Maize FB2 95 SPE (amino) LC-MS/MS 31 nd–334 [100]
Maize FB3 95 SPE (amino) LC-MS/MS 3 nd–67 [100]
Maize FB1 5 NA HPLC 100 4000–8000 [101]
Wheat FB1 5 NA HPLC 100 2500–6000 [101]
Sorghum FB1 5 NA HPLC 100 200–1400 [101]
Rapoko FB1 5 NA HPLC 100 300–2000 [101]
Peanut FB1 4 NA HPLC 25 0–1000 [101]
Burkina Faso, others = 30 (sorghum—7, millet—3, rice—3, sesame—2, wheat—1, infant food formulations—3, mixed cuscus—3, cornflakes—2, cookies—2, and dried fruits–4);
Mozambique, others = 7 (millet—2, soy—3, waste product from feed production—2); nd = not detected; NA = not applicable; LOQ = limit of quantification; FB = fumonisin;
∑FB = sum of FB1, B2, and B3; IAC = immunoaffinity column; SPE = solid phase extraction; SAX = strong anion exchange; HPLC/ESI-MS/MS = liquid chromatography/electrospray
ionization tandem mass spectrometry; ELISA = enzyme-linked immunosorbent assay; UHPLC/TOFMS = ultra-high performance liquid chromatography/time-of-flight mass
spectrometry; LC-MS/MS = liquid chromatography-tandem mass spectrometry; TLC = thin layer chromatography.
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2.2. Trichothecenes
Trichothecenes (THs) are a large group of structurally related sesquiterpenoid mycotoxins
produced by a wide range of Fusarium spp., although other mold genera such as Trichoderma,
Trichothecium, Stachybotrys, Verticimonosporium, Cephalosporium, Myrothecium, and Cylindrocarpon can
also synthesize them [102]. THs have a tetracyclic 12,13-epoxytrichothecene skeleton in common and
are divided into four categories based on their chemical properties, which include type A, B, C, and D.
Approximately 180 THs exist, but the ones of economic concern include those of type A (T-2 toxin (T-2),
HT-2 toxin (HT-2), and diacetoxyscirpenol (DAS)) and type B (deoxynivalenol (DON), nivalenol (NIV),
and fusarenon X (FX)) because of their frequent occurrence in food commodities and their toxic effects.
Ingestion of TH-contaminated food products have been associated with several human and
animal diseases probably because of an epoxide at the C12,13 positions, which exhibits toxicological
activity [103]. THs show varying degrees of cytotoxic potency based on the type, the dose, and
the duration of exposure. They have been revealed as inhibitors of eukaryotic protein synthesis as
well as DNA, RNA synthesis, and they affect cell division and inhibit mitochondrial function [5,104].
Prelusky et al. [105] and Rotter et al. [106] reported type A THs to be more acutely toxic, while
those belonging to type B are implicated in more chronic toxicoses. Of all the THs, clinical data
from animal studies suggest that T-2 and DAS are more potent [5]. In addition to inhibitors of
eukaryotic protein synthesis, T-2 and HT-2 induce hematotoxicity, myelotoxicity, growth retardation,
and necrotic lesion [107]. At low doses, DON exhibits toxicity often characterized in animals by feed
refusal, thus decreasing growth rate. In higher exposure rate, it expresses immunosuppressant and
immunostimulation properties. Epidemiological studies suggest the possibility of DON causing emetic
effects in humans [108]. In addition, the study of Razafimanjato et al. [109] revealed the potential of
DON decreasing the viability of glial cells responsible for maintaining brain homeostasis, thus causing
modifications of brain homeostasis and possibly participating in the etiology of neurological diseases
in which alteration of glial cells are involved. Similarly, NIV has been shown to exert clinical effects
such as hematotoxicity and immunotoxicity in mammals. Possible symptoms of TH toxicity include
vomiting, headache, dizziness, bleeding, nausea, fever, abdominal distress, dyspnea, and weight loss
abortion, and may lead to death, although the symptoms may vary with animal species. An association
of THs (T-2) with alimentary toxic aleukia in humans as a result of consumption of grains contaminated
with F. sporotrichioides was reported in the Orenburg region in Russia and led to the death of thousands
of people. A similar outbreak of a disease called akakabi-byo in Japan, as a result of consumption of
F. graminearum-contaminated grains, was also reported by Marasas et al. [110]. Other outbreaks of
acute poisoning in humans which exhibited symptoms such as vomiting, nausea, diarrhea, abdominal
pain, dizziness, and headache as a result of consumption of Fusarium-contaminated grains have also
been reported [111].
THs are commonly found in agricultural products, especially cereal crops such as wheat, maize,
barley, oats, rye, rice, and other cereal-based foods, worldwide. Natural occurrence of DON in cereals
is prevalent, and surveys from South America, Canada, China, and many countries of Europe have
shown frequent occurrence, as well as high levels in cereal crops. In Europe, type B THs seem to be the
most dominant [3], and this has expedited the establishment of regulatory limits for these toxins in
various foodstuffs in order to avoid outbreaks of toxicoses [112]. Contrary to the state of research on
THs in Europe and other parts of the world, SSA has paid little attention to TH research. Available
published data (Table 2) suggest evidence of high occurrence of THs in SSA, and high concentrations
up to 3842 µg/kg of DON in maize were reported as well [40]. Furthermore, the ability of THs to
co-occur in food commodities as observed by some authors (Table 2) raises important issues regarding
synergistic and/or additive effects in humans and animals [113]. However, the TH occurrence data in
SSA is grossly inadequate, and this explains why there are no TH regulations despite the fact there is
evidence of occurrence of these mycotoxins.
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Table 2. Occurrence and contamination levels of trichothecenes in food crops and products in sub-Saharan Africa since the year 2000.
Country Sample Type Toxin Type No of Samples Sample Preparation Technique % Positive Range (µg/kg) Reference
Burkina Faso
Maize DON 26 NA HPLC/ESI-MS/MS 4 31.4 (median) [68]
Others DON 30 NA HPLC/ESI-MS/MS 33.33 22.3–250 [68]
Others NIV 30 NA HPLC/ESI-MS/MS 3.33 40.2 (median) [68]
Cameroon
Maize DON 18 NA ELISA 77.8 nd–1300 [70]
Maize DON 40 SPE (SAX) HPLC 72.5 18–273 [69]
Peanut DON 16 SPE (SAX) HPLC 75 17–270 [69]
Bean DON 15 SPE (SAX) HPLC 46.7 13–35 [69]
Soybeans DON 5 SPE (SAX) HPLC 40 13–207 [69]
Miscellaneous DON 6 SPE (SAX) HPLC 50 13–35 [69]
Sorghum beer DON 120 SPE (C18) ELISA 89.2 0–730 µg/L [71]
Maize DON 165 SPE (amino) UPLC-MS/MS 12 27–3842 [40]
Maize DON 37 NA LC-MS/MS 100 43–435 [72]
Soybean DON 10 NA LC-MS/MS 100 56–75 [72]
Maize beer DON 14 NA LC-MS/MS 93 3–57 [72]
Groundnut soup DON 15 NA LC-MS/MS 27 0.96–1.8 [72]
Dagwa DON 8 NA LC-MS/MS 100 12–116 [72]
Maize NIV 37 NA LC-MS/MS 100 3–782 [72]
Soybean NIV 10 NA LC-MS/MS 90 0.3–0.5 [72]
Maize beer NIV 14 NA LC-MS/MS 57 3–90 [72]
Dagwa NIV 8 NA LC-MS/MS 100 51–155 [72]
Maize FX 37 NA LC-MS/MS 86 <LOQ–112 [72]
Soybean FX 10 NA LC-MS/MS 100 33–42 [72]
Ethiopia
Maize DON 17 SPE (C18) HPLC 29.4 50–700 [76]
Maize NIV 17 SPE (C18) HPLC 17.7 50–210 [76]
Barley DON 20 NA HPLC 35 40–110 [75]
Sorghum DON 33 NA HPLC 90.9 50–2340 [75]
Sorghum NIV 33 NA HPLC 9.1 50–490 [75]
Wheat DON 23 NA HPLC 17.4 50–110 [75]
Wheat NIV 23 NA HPLC 4.4 40 (mean) [75]
Sorghum DON 70 NA HPLC/ESI-MS/MS 2.86 nd–78.1 [77]
Sorghum NIV 70 NA HPLC/ESI-MS/MS 5.71 nd–54.9 [77]
Sorghum DAS 70 NA HPLC/ESI-MS/MS 35.7 nd–64.2 [77]
Millet DON 34 NA HPLC/ESI-MS/MS 9.09 nd–4.1 [77]
Millet NIV 34 NA HPLC/ESI-MS/MS 12.1 nd–8.1 [77]
Millet DAS 70 NA HPLC/ESI-MS/MS 3.03 nd–1.4 [77]
Kenya
Wheat DON 82 NA ELISA 68.3 105–303 [36]
Wheat T2 80 NA ELISA 76.3 20–66 [36]
Maize beer DON 61 NA QuickTox Kit 23 200–360 [80]
Wheat kernels HT2 26 NA LC-MS/MS 11.5 124–239 [114]
Wheat Kernels FX 26 NA LC-MS/MS 15.4 14–294 [114]
Wheat Kernels NEO 26 NA LC-MS/MS 11.5 20–51 [114]
Wheat kernels NIV 26 NA LC-MS/MS 7.7 25–60 [114]
Wheat kernels DON 26 NA LC-MS/MS 69.2 25–1310 [114]
Kenyan Lager Beers DON 75 SPE (C18) ELISA 100 1.56–6.4 µg/L [81]
Malawi
Maize DON 90 NA HPLC/ESI-MS/MS 99 nd–2328 [82]
Maize NIV 90 NA HPLC/ESI-MS/MS 84 nd–2220 [82]
Maize DAS 90 NA HPLC/ESI-MS/MS 37 nd–17 [82]
Maize FX 90 NA HPLC/ESI-MS/MS 32 nd–664 [82]
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Country Sample Type Toxin Type No of Samples Sample Preparation Technique % Positive Range (µg/kg) Reference
Mozambique
Maize DON 13 NA HPLC/ESI-MS/MS 15.4 116–124 [68]
Maize NIV 13 NA HPLC/ESI-MS/MS 30.8 20.2–45.9 [68]
Feed DON 10 NA HPLC/ESI-MS/MS 50 99.1–697 [68]
Others DON 7 NA HPLC/ESI-MS/MS 14 145 (median) [68]
Feed NIV 10 NA HPLC/ESI-MS/MS 20 42.7–52.7 [68]
Others NIV 7 NA HPLC/ESI-MS/MS 29 76.8–113 [68]
Maize DON 70 NA HPLC/ESI-MS/MS 100 11–479 [39]
Maize NIV 70 NA HPLC/ESI-MS/MS 54.3 0.7–164 [39]
Maize DON 180 NA LC-MS/MS 22 9.6–745.1 [115]
Maize DAS 180 NA LC-MS/MS 9 1.0–51.0 [115]
Maize DON 136 SPE (C18), MultiSep LC-MS/MS 16 99 (mean) [88]
Maize HT-2 136 SPE (C18), MultiSep LC-MS/MS 1 20 (mean) [88]
Maize NIV 136 SPE (C18), MultiSep LC-MS/MS 2 206 (mean) [88]
Maize FX 136 SPE (C18), MultiSep LC-MS/MS 1 154 (mean) [88]
Maize DAS 136 SPE (C18), MultiSep LC-MS/MS 13 3 (mean) [88]
Sorghum DON 110 SPE (C18), MultiSep LC-MS/MS 3 100 (mean) [88]
Sorghum HT-2 110 SPE (C18), MultiSep LC-MS/MS 8 20 (mean) [88]
Nigeria
Sorghum DAS 110 SPE (C18), MultiSep LC-MS/MS 18 5 (mean) [88]
Millet DON 87 SPE (C18), MultiSep LC-MS/MS 13 151 (mean) [88]
Millet HT-2 87 SPE (C18), MultiSep LC-MS/MS 5 36 (mean) [88]
Millet DAS 87 SPE (C18), MultiSep LC-MS/MS 29 5 (mean) [88]
Ogi DON 30 SPE (C18), MultiSep LC-MS/MS 13 61 (mean) [88]
Ogi HT-2 30 SPE (C18), MultiSep LC-MS/MS 3 13 (mean) [88]
Ogi NIV 30 SPE (C18), MultiSep LC-MS/MS 7 148 (mean) [88]
Ogi FX 30 SPE (C18), MultiSep LC-MS/MS 7 133 (mean) [88]
Maize snack NIV 8 NA HPLC/ESI-MS/MS 25 1.8–2.5 [85]
Rice DON 21 NA HPLC 23.8 11.2–112.2 [89]
Republic of Benin Cassava flour DAS 4 SPE (amino) UPLC-MS/MS 100 <LOD–5 [93]
South Africa
Maize meal DON 18 IAC HPLC 88.9 0–960 [116]
Wheat flour DON 23 IAC HPLC 69.6 0–100 [116]
Compound feed DON 91 SPE (SAX) HPLC 70.3 124–2352 [96]
Maize DON 54 IAC LC-MS/MS 32 4.2–675 [38]
Tanzania Maize DON 60 NA UHPLC/TOFMS 63.33 68–2196 [98]Maize HT2 60 NA UHPLC/TOFMS 25 15–25 [98]
Zimbabwe
Maize DAS 95 SPE (amino) LC-MS/MS 1 nd–14 [100]
Maize DON 95 SPE (amino) LC-MS/MS 24 nd–492 [100]
Maize NIV 95 SPE (amino) LC-MS/MS 3 nd–530 [100]
Burkina Faso, others = 30 (sorghum—7, millet—3, rice—3, sesame—2, wheat—1, infant food formulations—3, mixed cuscus—3, cornflakes—2, cookies—2 and dried fruits–4);
Mozambique, others = 7 (millet—2, soy—3, waste product from feed production—2); Cameroon, miscellaneous = 6 (rice, pumpkin seeds (egusi), fermented cassava flakes (garri),
fermented cassava flour (nkum nkum)); nd = not detected; NA = not applicable; LOD = limit of detection; LOQ = limit of quantification; DON = deoxynivalenol; NIV = nivalenol;
T2 = T-2 toxin; HT2 = HT-2 toxin; DAS = diacetoxyscirpenol; FX = Fusarenon X; NEO = neosolaniol; IAC = immunoaffinity column; SPE = solid phase extraction; SAX = strong anion
exchange; ELISA = enzyme-linked immunosorbent assay; HPLC/ESI-MS/MS = liquid chromatography/electrospray ionization tandem mass spectrometry; UHPLC/TOFMS = ultra
high performance liquid chromatography/time-of-flight mass spectrometry; LC-MS/MS = liquid chromatography-tandem mass spectrometry.
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2.3. Zearalenone
Zearalenone (ZEN) is a secondary metabolite produced by a variety of Fusarium fungi
species including F. graminearum, F. culmorum, F. verticillioides, F. cerealis, F. equiseti, F. crookwellense,
and F. semitectum. These fungi contaminate crops in the field and thus produce ZEN prior to harvest.
However, production of ZEN during storage have equally been reported by Kuiper-Goodman et al. [117],
who observed high-level production of ZEN in maize-based feed as a result of improper storage.
ZEN is commonly found in cereal crops, though its occurrence in other food products such as
soybean products, dried fruit and vegetables, and cheese snacks have also been reported [118–120].
ZEN often co-occurs with other mycotoxins including DON, 15-acetyldeoxynivalenol (15-ADON),
3-acetyldeoxynivalenol (3-ADON), NIV, and FX because of the ability of the producing fungi to
synthesize more than one mycotoxin which often results to synergistic and/or additive effects on the
host organism [6].
ZEN is a non-steroidal estrogenic mycotoxin affecting both animals and humans. It has
high binding affinities for the intracellular estrogen receptor and can enhance the proliferation of
estrogen-responsive tumor cells [121]. Studies have reported the ability of ZEN to stimulate the growth
of estrogen-responsive positive cells, increase uterine weight, modulate the estrous cycle and compete
with estradiol for estrogen-responsive binding [122]. Its occurrence in foods and feeds has been linked
to mammary tumorigenesis and hyperestrogenism, especially in pigs, resulting in adverse effects on
the reproductive performance of breeding animals [123]. In addition, ZEN has been alleged to cause
human cervical cancer and premature initial breast development [124], and an epidemic of precocious
pubertal changes in young children in Puerto Rico between 1978 and 1981 [125]. Other authors also
reported a possible link between ZEN and the incidence of esophageal cancer in certain parts of
the world in combination with other mycotoxins such as fumonisins and trichothecenes [126,127].
Ingestion of ZEN has exhibited symptoms such as enlargement of mammary glands, vaginal and
rectal prolapses, vaginal swelling (vulvovaginitis), testicular atrophy, infertility, prolonged estrus and
reduced sexual drive, stillbirths, abortion, and reduced litter size [105,128]. Despite the wealth of
information on the toxic effects of ZEN on the health of both humans and animals, and the evidence of
high occurrence and levels of ZEN in food and food products exceeding the maximum limit set by the
EU (Table 3), there is still a knowledge gap as regards the occurrence of ZEN in SSA.
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Table 3. Occurrence and contamination levels of zearalenone in food crops and products in sub-Saharan Africa since the year 2000.
Country Sample Type No of Samples Sample Preparation Technique % Positive Range (µg/kg) Reference
Burkina Faso
Maize 26 NA HPLC/ESI-MS/MS 8 11.0–15.8 [68]
Feed 4 NA HPLC/ESI-MS/MS 50 43.9–54.3 [68]
Others 30 NA HPLC/ESI-MS/MS 29 12.3–17.0 [68]
Cameroon
Maize 40 SPE (SAX) HPLC 77.5 28–273 [69]
Maize 18 NA ELISA 83.3 nd–1100 [70]
Peanut 16 SPE (SAX) HPLC 62.5 31–186 [69]
Bean 15 SPE (SAX) HPLC 33.3 27–157 [69]
Miscellaneous 6 SPE (SAX) HPLC 16.7 67 (mean) [69]
Maize 37 NA LC-MS/MS 89 0.2–309 [72]
Groundnut 35 NA LC-MS/MS 43 <LOQ–45 [72]
Soybean 10 NA LC-MS/MS 100 12–18 [72]
Maize beer 14 NA LC-MS/MS 86 1.6–35 [72]
Kuru-Kuru 6 NA LC-MS/MS 17 <LOQ [72]
Dagwa 8 NA LC-MS/MS 100 6–57 [72]
Côte d’Ivoire
Maize 10 NA ELISA 100 20–50 [73]
Rice 10 NA ELISA 100 50–200 [73]
Peanut 10 NA ELISA 100 50–200 [73]
Democratic Republic
of Congo
Maize 40 SPE (SAX), (IAC) TLC, HPLC 92.5 24–811.2 [74]
Bean 30 SPE (SAX), (IAC) TLC, HPLC 90 12.5–273.2 [74]
Ethiopia
Sorghum 29 NA HPLC 6.9 19–32 [75]
Sorghum 70 NA HPLC/ESI-MS/MS 32.9 nd–374 [77]
Millet 34 NA HPLC/ESI-MS/MS 51.5 nd–459 [77]
Kenya
Wheat 82 NA ELISA 57.3 1–96 [36]
Wheat kernels 26 NA LC-MS/MS 26.9 7–55 [114]
Kenyan Lager Beers 75 SPE (C18) ELISA 100 4.3–10.2 µg/L [81]
Malawi Maize 90 NA HPLC/ESI-MS/MS 68 nd–2025 [82]
Mozambique
Maize 13 NA HPLC/ESI-MS/MS 23.1 10.9–18.1 [68]
Feed 10 NA HPLC/ESI-MS/MS 60 11.2–28.2 [68]
Others 7 NA HPLC/ESI-MS/MS 43 78.8–318 [68]
Maize 182 NA LC-MS/MS 57 115–779 [84]
Maize 69 NA HPLC 5.8 2–13 [129]
Maize 70 NA HPLC/ESI-MS/MS 17.1 0.4–2044 [39]
Nigeria
Rice 196 NA TLC 47.5 0–1169 [130]
Rice 21 NA HPLC 52.4 8.8–41.9 [89]
Maize 136 SPE (C18), MultiSep LC-MS/MS 1 65 (mean) [88]
Sorghum 110 SPE (C18), MultiSep LC-MS/MS 1 38 (mean) [88]
Millet 87 SPE (C18), MultiSep LC-MS/MS 14 419 (mean) [88]
Ogi 30 SPE (C18), MultiSep LC-MS/MS 3 39 (mean) [88]
Republic of Benin Cassava flour 4 SPE (amino) UPLC-MS/MS 100 <LOQ–12 [93]
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Table 3. Cont.
Country Sample Type No of Samples Sample Preparation Technique % Positive Range (µg/kg) Reference
South Africa
Traditional Beer 32 NA TLC, HPLC 21.9 2.6–426 µg/L [131]
Maize 40 SPE (SAX) HPLC 90 0–135 [37]
Compound feed 91 SPE (SAX) HPLC 51.6 30–610 [96]
Maize 54 IAC LC-MS/MS 100 56–14,990 [38]
Tanzania Maize 60 NA UHPLC/TOFMS 5 651–1464 [98]
Zimbabwe Maize 95 SPE (amino) LC-MS/MS 15 nd–369 [100]
Burkina Faso, others = 30 (sorghum—7, millet—3, rice—3, sesame—2, wheat—1, infant food formulations—3, mixed cuscus—3, cornflakes—2, cookies—2 and dried fruits–4);
Mozambique, others = 7 (millet—2, soy—3, waste product from feed production—2); Cameroon, miscellaneous = 6 (rice, pumpkin seeds (egusi), fermented cassava flakes (garri),
fermented cassava flour (nkum nkum); nd = not detected; NA = not applicable; LOQ = limit of quantification; IAC = immunoaffinity column; SPE = solid phase extraction; SAX =
strong anion exchange; ELISA = enzyme-linked immunosorbent assay; HPLC/ESI-MS/MS = liquid chromatography/electrospray ionization tandem mass spectrometry; TLC =
thin layer chromatography; UHPLC/TOFMS = ultra high performance liquid chromatography/time-of-flight mass spectrometry; LC-MS/MS = liquid chromatography-tandem
mass spectrometry.
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2.4. Emerging and Modified Fusarium Mycotoxins
Studies on Fusarium mycotoxins have primarily focused on the occurrence and toxicological
effects of FB, TH, and ZEN on humans and animals as well as prevention and detoxification strategies
of these mycotoxins in food chains. However, in recent years, mycotoxin research has broadened
upon other Fusarium mycotoxins such as fusaproliferin (FUS), beauvericin (BEA), enniatins (ENN),
and moniliformin (MON) often called emerging Fusarium mycotoxins. Evidence of their occurrence
in different food products has been reported [13,132–138], thus posing a severe challenge in some
parts of the world. Little or no appreciable study has been carried out on the occurrence of these
mycotoxins in food and food products in SSA (Table 4). Neglecting these Fusarium mycotoxins
increases the risk of exposure of humans and animals to mycotoxin toxicity because of the possible
high incidence and concentration in cereals and cereal-based products, which serve as staple foods in
the region. BEA and ENN have shown cytotoxic and apoptotic effect on several humans cell lines and
animal species [139,140]. They also act as specific inhibitors to the cholesterol acyltransferase [141,142].
In addition, ENN has been found to have a synergistic, additive, and antagonistic toxic effects on
Caco-2 cells because of the possible co-occurrence of ENN analogues [143]. MON is a potent inhibitor
of the pyruvate dehydrogenase complex, inducing cardiotoxicity, immunosuppression, muscular
weakness, and intestinal problems [144–146]. On the other hand, FUS has exhibited teratogenic and
pathogenic effects on human B-lymphocyte cells [147].
Apart from the emerging Fusarium mycotoxins, a recent concern is the occurrence of modified
mycotoxins. These toxins are often not detectable by basic routine analytical methods, thus
leading to an underestimation of the mycotoxin concentration. Modified mycotoxins may be
matrix-associated or generated as a result of the modification of the chemical structure of free
mycotoxins by plant, animal or fungus metabolism, or during food processing. However, some
free mycotoxins may also be classified as modified mycotoxins, especially the acetylated DON
(3- and 15-acetyldeoxynivalenol) [17]. It is noteworthy to highlight that, in an attempt to detoxify
DON, plants genetic transformation by implementing a 3-O-acetyltransferase allows for the acetylation
of DON to 3-acetyldeoxynivalenol (3-ADON), a trait which plants do not possess naturally, thereby
classifying 3-ADON under biologically modified mycotoxin [148,149]. Several studies have revealed
the occurrence of modified forms of ZEN, TH, and FB mycotoxins in cereals, cereal-based food,
and feed products [19,21,113,150–152]. However, there seems to be little or no available data on
modified mycotoxins in SSA (Table 4). Though toxicological data are still limited, the occurrence of
modified mycotoxins is extrapolated to add substantially to the overall mycotoxins levels and toxicity.
The increase in toxic health effects by modified mycotoxins may be either direct or indirect via
hydrolysis, or released from the matrix during digestion into the free compounds [153]. Comparative
cytotoxic effects of DON and its acetylated derivatives on a non-transformed intestinal epithelial cell
line using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) revealed that 3-ADON
exerted less toxic effects (EC80 value of 125 µM) when compared to the free toxin (EC80 value of
16.5 µM) while the reverse was the case with 15-ADON (EC80 value of 10.5 µM) [154]. Their findings
were in agreement with the previous studies of Pinton et al. [155] and Kadota et al. [156],
who compared the toxicity of DON, 3-ADON, and 15-ADON on porcine intestinal epithelial cells and
human intestinal Caco-2 cell, respectively. Pinton et al. [155] reported a reduction in cell proliferation
by DON and its acetylated derivatives in the ranking order of 3-ADON (13%) < DON (60%) <
15-ADON (69%), while Kadota et al. [156] observed the same trend on the interleukin-8 production in
Caco-2 cell. Further ex vivo (porcine intestinal explants) and in vivo (jejunum from piglets) analysis
showed that 15-ADON exerted more toxicity than DON and 3-ADON [155]. A much earlier study by
Forsell et al. [157] buttressed this view when mice were exposed to acute oral toxicity of DON and
15-ADON. DON and its metabolites are able to increase the permeability of the intestinal epithelial
layer by decreasing the expression of tight junction proteins [152]. This can be worsened by a reduction
in cell proliferation, thus increasing susceptibility to pathogens. While the consistency of results
suggests a trend, these protocols need to be replicated in different animal models while minimizing
Toxins 2017, 9, 19 15 of 36
variations within experimental units. The co-contamination of DON with other mycotoxins and
metabolites of DON, and their potential synergistic and additive effects remains a knowledge gap.
Eriksen et al. [158] compared DON, its acetylated and deepoxy metabolites on Swiss mouse
3T3 fibroblasts. Their findings showed a similar lower toxic effect by 3-ADON, whereas DON
and 15-ADON had equal effects. De-epoxy deoxynivalenol (DOM) was 50 times less toxic than
DON [158]. The reduced toxic effect of DOM is attributed to the de-epoxidation of the 12,13-epoxy
ring in the structure of TH which is the essential functional group alleged to cause toxicity [159].
Regarding glucosylated form of DON, Pierron et al. [160] studied the possible toxic effect of
deoxynivalenol-3-glucoside (DON-3G) in comparison with DON on the intestine using the human
intestinal Caco-2 cell line and porcine jejunal explants. Their investigation revealed the inability of
DON-3G to bind to the ribosome, thus decreasing its intestinal toxicity when compared to DON. This
is in line with the in vitro cytotoxicity study of DON-3G on porcine intestinal epithelial cells ranking
DON-3G as the least toxic compared to DON and its acetylated forms [161]. In addition, an in vivo
study by Broekaert et al. [162] demonstrated that DON-3G has a low absolute oral bioavailability in
broiler chickens compared to DON. DON-3G is not hydrolyzed to DON in broiler chicken similar
to the trend reported in different in vitro studies [163,164]. In contrast with the study on broiler
chicken, Broekaert et al. [162] observed a different trend when pigs were orally administered with
DON-3G demonstrating a complete hydrolysis of DON-3G to DON although the absorbed fraction
was approximately 5 times lower than after oral administration of DON [162]. While in vitro studies
of DON-3G suggest less toxic effects, the latter study on pig proves that the toxicological significance
of DON-3G should not be neglected especially across different animal species. Apart from the
ability of modified metabolites of DON to exert direct toxic effect on animal or human host, a
major concern is their hydrolyses into their free forms after ingestion. Studies have reported the
possible potentials of these metabolites being hydrolyzed to their free forms [15,16]. In order to
understand the transformation of 3-ADON and 15-ADON to DON, Ajandouz et al. [16] studied the
deacetylation activity of 3-ADON and 15-ADON by enzymes, bacteria, cells, and tissues present in
humans. Interestingly, they observed that 3-ADON was more prone to deacetylation than 15-ADON,
while small intestine and liver are the major sites of deacetylation of 3-ADON and 15-ADON in
humans. The toxicity of 4-acetyl NIV (FUS X) on Swiss mouse 3T3 fibroblasts showed that 4-acetyl
NIV exhibited 1.7 times more toxic effects than NIV [158]. This trend was also observed in previous
studies by Visconti et al. [165], and Eriksen and Alexander [166]. These findings were in line with the
study of de-epoxy T-2 using rat skin irritation assay. Their result showed that de-epoxy T-2 exhibited
400 times less toxic effect than the corresponding T-2 [167]. Similarly, the cytotoxicity effects of ZEN and
its major metabolites alpha-zearalenol (α-ZEL) and beta-zearalenol (β-ZEL) on cultured human Caco-2
cells revealed variable toxic effects of ZEN and its metabolites with observation showing that the toxic
effects seem to be relieved by the metabolism of ZEN into α-ZEL and β-ZEL [168]. Othmen et al. [169]
reported that α-ZEL and β-ZEL inhibited cell viability, protein and DNA syntheses, and induced
oxidative damage, and over-expression of stress proteins. However, α-ZEL and β-ZEL exhibited lesser
toxicity than ZEN, with β-ZEL being the more active of the two metabolites. A reverse toxicity trend
was observed in the estrogenic potential of these compounds [170], with α-ZEL being ranked as the
most toxic, followed by ZEN, and then β-ZEL. This trend of toxic effect was shown by Ayed et al. [171].
Zearalenone-14-sulfate (ZEN-14S) and zearalenone-14-glucoside (ZEN-14G) exhibited low estrogenic
potential which is attributed to their inability to bind to the estrogen receptor [172,173]. Apart from
the low estrogenic potential of ZEN-14G, an in vitro study also showed a lower toxicity of ZEN-14G
with respect to its free form (ZEN). Dellafiora et al. [174] studied the hydrolysis of ZEN-14G to its free
form (ZEN) in the bovine blood and blood components including plasma, serum, and serum albumin.
Their study revealed the reduction in ZEN-14G in all the treatments, thus leading to the release of ZEN
with a significant amount of zearalenol isomers (α-ZEL and β-ZEL) in whole blood.
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Table 4. Occurrence and contamination levels of emerging and modified Fusarium mycotoxins in food crops and processed food products in sub-Saharan Africa since
the year 2000.
Country Sample Type Mycotoxin Type No of Samples Sample Preparation Technique % Positive Range (µg/kg) Reference
Burkina Faso
Others DON-3G 30 NA HPLC/ESI-MS/MS 7 23.6–39.7 [68]
Maize MON 26 NA HPLC/ESI-MS/MS 8 413–1025 [68]
Feed MON 4 NA HPLC/ESI-MS/MS 25 48(median) [68]
Others MON 30 NA HPLC/ESI-MS/MS 18 70.2–320 [68]
Others ENN A 30 NA HPLC/ESI-MS/MS 21 0.3–1.4 [68]
Feed ENN A1 4 NA HPLC/ESI-MS/MS 25 0.1 (median) [68]
Others ENN A1 30 NA HPLC/ESI-MS/MS 29 0.2–9.1 [68]
Others ENN B 30 NA HPLC/ESI-MS/MS 29 1.2–16.4 [68]
Maize ENN B1 26 NA HPLC/ESI-MS/MS 4 0.2 (median) [68]
Others ENN B1 30 NA HPLC/ESI-MS/MS 29 0.9–21.4 [68]
Others ENN B2 30 NA HPLC/ESI-MS/MS 14 0.2–0.8 [68]
Maize BEA 26 NA HPLC/ESI-MS/MS 54 0.1–5.9 [68]
Groundnut BEA 9 NA HPLC/ESI-MS/MS 11 0.1 (median) [68]
Feed BEA 4 NA HPLC/ESI-MS/MS 75 25.4–31.7 [68]
Cameroon
Maize DON-3G 37 NA LC-MS/MS 100 <LOQ–82 [72]
Soybean DON-3G 10 NA LC-MS/MS 100 <LOQ–1 [72]
Maize beer DON-3G 14 NA LC-MS/MS 86 0.3–27 [72]
Dagwa DON-3G 8 NA LC-MS/MS 100 4–90 [72]
Maize beer α-ZEL 14 NA LC-MS/MS 86 0.6–2 [72]
Groundnut soup α-ZEL 15 NA LC-MS/MS 20 0.4–0.5 [72]
Maize beer β-ZEL 14 NA LC-MS/MS 93 0.03–8 [72]
Groundnut soup β-ZEL 15 NA LC-MS/MS 53 0.03–0.4 [72]
Maize beer ZEN-4S 14 NA LC-MS/MS 93 0.01–0.6 [72]
Groundnut soup ZEN-4S 15 NA LC-MS/MS 13 0.001–0.01 [72]
Maize ENN A 37 NA LC-MS/MS 38 <LOQ–0.04 [72]
Groundnut ENN A 35 NA LC-MS/MS 57 <LOQ–0.1 [72]
Groundnut soup ENN A 15 NA LC-MS/MS 87 <LOQ–0.1 [72]
Groundnut ENN A1 35 NA LC-MS/MS 29 <LOQ–6 [72]
Groundnut soup ENN A1 15 NA LC-MS/MS 100 <LOQ–0.2 [72]
Kuru-kuru ENN A1 6 NA LC-MS/MS 87 <LOQ [72]
Dagwa ENN A1 8 NA LC-MS/MS 38 <LOQ–0.04 [72]
Maize ENN B 37 NA LC-MS/MS 68 <LOQ–0.07 [72]
Groundnut ENN B 35 NA LC-MS/MS 91 <LOQ–0.6 [72]
Soybean ENN B 10 NA LC-MS/MS 10 <LOQ [72]
Maize beer ENN B 14 NA LC-MS/MS 50 0.004–0.02 [72]
Groundnut soup ENN B 15 NA LC-MS/MS 100 <LOQ–0.2 [72]
Kuru-Kuru ENN B 6 NA LC-MS/MS 100 0.02–0.03 [72]
Dagwa ENN B 8 NA LC-MS/MS 88 <LOQ–0.1 [72]
Maize ENN B1 37 NA LC-MS/MS 89 <LOQ–1 [72]
Groundnut ENN B1 35 NA LC-MS/MS 91 0.02–5 [72]
Soybean ENN B1 10 NA LC-MS/MS 50 0.01–0.04 [72]
Maize beer ENN B1 14 NA LC-MS/MS 57 0.01–0.4 [72]
Groundnut soup ENN B1 15 NA LC-MS/MS 93 0.01–0.3 [72]
Kuru-Kuru ENN B1 6 NA LC-MS/MS 100 0.2–0.4 [72]
Dagwa ENN B1 8 NA LC-MS/MS 100 0.01–0.8 [72]
Maize BEA 37 NA LC-MS/MS 100 0.3–93 [72]
Groundnut BEA 35 NA LC-MS/MS 100 0.2–12 [72]
Soybean BEA 10 NA LC-MS/MS 100 12–19 [72]
Maize beer BEA 14 NA LC-MS/MS 93 2–11 [72]
Groundnut soup BEA 15 NA LC-MS/MS 100 0.04–1 [72]
Kuru-Kuru BEA 6 NA LC-MS/MS 100 0.6–0.9 [72]
Dagwa BEA 8 NA LC-MS/MS 100 3.4–31 [72]
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Table 4. Cont.
Country Sample Type Mycotoxin Type No of Samples Sample Preparation Technique % Positive Range (µg/kg) Reference
Sorghum DON-3G 70 NA HPLC/ESI-MS/MS 7.14 nd–4.7 [77]
Sorghum ZEN-4S 70 NA HPLC/ESI-MS/MS 5.71 nd–2.4 [77]
Sorghum α-ZEL 70 NA HPLC/ESI-MS/MS 7.14 nd–8.3 [77]
Sorghum β-ZEL 70 NA HPLC/ESI-MS/MS 8.57 nd–23.8 [77]
Sorghum ENN B 70 NA HPLC/ESI-MS/MS 47.1 nd–0.7 [77]
Sorghum ENN B1 70 NA HPLC/ESI-MS/MS 44.3 nd–2.7 [77]
Sorghum ENN A1 70 NA HPLC/ESI-MS/MS 38.6 nd–4.0 [77]
Sorghum ENN A 70 NA HPLC/ESI-MS/MS 21.4 nd–0.8 [77]
Sorghum BEA 70 NA HPLC/ESI-MS/MS 71.4 nd–290 [77]
Sorghum MON 70 NA HPLC/ESI-MS/MS 97.1 nd–316 [77]
Sorghum FA 70 NA HPLC/ESI-MS/MS 7.14 nd–239 [77]
Millet α-ZEL 34 NA HPLC/ESI-MS/MS 21.2 nd–6.5 [77]
Millet β-ZEL 34 NA HPLC/ESI-MS/MS 24.2 nd–4.4 [77]
Ethiopia
Millet ZEN-4S 34 NA HPLC/ESI-MS/MS 42.4 nd–13.9 [77]
Millet MAS 34 NA HPLC/ESI-MS/MS 3.03 nd–2.7 [77]
Millet BEA 34 NA HPLC/ESI-MS/MS 100 85.6 (maximum) [77]
Millet ENN B 34 NA HPLC/ESI-MS/MS 69.7 nd–1.8 [77]
Millet ENN B1 34 NA HPLC/ESI-MS/MS 78.8 nd–5.3 [77]
Millet ENN A1 34 NA HPLC/ESI-MS/MS 57.6 nd–3.0 [77]
Millet ENN A 34 NA HPLC/ESI-MS/MS 21.2 nd–0.4 [77]
Millet FA 34 NA HPLC/ESI-MS/MS 18.2 nd–241 [77]
Millet MON 34 NA HPLC/ESI-MS/MS 57.6 nd–46.9 [77]
Kenya
Wheat Kernels 3-ADON 26 NA LC-MS/MS 34.6 80–1703 [114]
Wheat Kernels 15-MAS 26 NA LC-MS/MS 7.7 42–107 [114]
Wheat Kernels MON 26 NA LC-MS/MS 7.7 5–17 [114]
Wheat Kernels ENN B 26 NA LC-MS/MS 50 2–256 [114]
Wheat Kernels BEA 26 NA LC-MS/MS 7.7 13–15 [114]
Malawi
Maize BEA 90 NA HPLC/ESI-MS/MS 99 nd–415 [82]
Maize MON 90 NA HPLC/ESI-MS/MS 94 nd–1624 [82]
Maize FA 90 NA HPLC/ESI-MS/MS 72 nd–1020 [82]
Maize FUS 90 NA HPLC/ESI-MS/MS 70 nd–2056 [82]
Maize HYD FB1 90 NA HPLC/ESI-MS/MS 61 nd–30 [82]
Maize ZEN-4S 90 NA HPLC/ESI-MS/MS 50 nd–80 [82]
Maize DON-3G 90 NA HPLC/ESI-MS/MS 28 nd–268 [82]
Maize ENN 90 NA HPLC/ESI-MS/MS 20 nd–9.5 [82]
Maize β-ZEL 90 NA HPLC/ESI-MS/MS 18 nd–124 [82]
Maize α-ZEL 90 NA HPLC/ESI-MS/MS 7 nd–56 [82]
Maize T-2T 90 NA HPLC/ESI-MS/MS 3 nd–123 [82]
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Table 4. Cont.
Country Sample Type Mycotoxin Type No of Samples Sample Preparation Technique % Positive Range (µg/kg) Reference
Maize MON 13 NA HPLC/ESI-MS/MS 54 98–1305 [68]
Feed MON 10 NA HPLC/ESI-MS/MS 80 61.0–1601 [68]
Others MON 7 NA HPLC/ESI-MS/MS 57 46.8–1923 [68]
Feed ENN A 10 NA HPLC/ESI-MS/MS 40 0.6–7.9 [68]
Others ENN A 7 NA HPLC/ESI-MS/MS 29 0.2–2.0 [68]
Maize ENN A1 13 NA HPLC/ESI-MS/MS 15 0.1–0.1 [68]
Feed ENN A1 10 NA HPLC/ESI-MS/MS 40 3.4–43.9 [68]
Others ENN A1 7 NA HPLC/ESI-MS/MS 29 0.2–4.1 [68]
Mozambique
Feed ENN B 10 NA HPLC/ESI-MS/MS 40 2.2–114 [68]
Others ENN B 7 NA HPLC/ESI-MS/MS 14 0.9 (median) [68]
Maize ENN B1 13 NA HPLC/ESI-MS/MS 8 0.1 (median) [68]
Groundnut ENN B1 23 NA HPLC/ESI-MS/MS 5 0.3 (median) [68]
Feed ENN B1 10 NA HPLC/ESI-MS/MS 70 0.1–94.4 [68]
Others ENN B1 7 NA HPLC/ESI-MS/MS 14 4.1 (median) [68]
Feed ENN B2 10 NA HPLC/ESI-MS/MS 30 0.9–9.1 [68]
Maize BEA 13 NA HPLC/ESI-MS/MS 85 0.1–35.6 [68]
Groundnut BEA 23 NA HPLC/ESI-MS/MS 73 0.1–24.0 [68]
Feed BEA 10 NA HPLC/ESI-MS/MS 100 3.3–418 [68]
Others BEA 7 NA HPLC/ESI-MS/MS 100 3.5–486 [68]
Nigeria
Maize α-ZEL 182 NA LC-MS/MS 14 32–181 [84]
Stored Maize α-ZEL 70 NA HPLC/ESI-MS/MS 1.4 17 (mean) [39]
Stored Maize β-ZEL 70 NA HPLC/ESI-MS/MS 1.4 13 (mean) [39]
Maize 3-ADON 180 NA LC-MS/MS 17.2 0.7–72 [115]
Stored Maize BEA 70 NA HPLC/ESI-MS/MS 78.6 0.1–120 [39]
Groundnut Snack BEA 10 NA HPLC/ESI-MS/MS 60 2–84 [85]
Maize Snack BEA 8 NA HPLC/ESI-MS/MS 100 0.6–5.2 [85]
Groundnut/Maize
snack BEA 2 NA HPLC/ESI-MS/MS 100 1.8–1.9 [85]
Maize Snack ENN B2 8 NA HPLC/ESI-MS/MS 12.5 0.1(mean) [85]
Stored Maize FUS 70 NA HPLC/ESI-MS/MS 4.3 57.4–263 [39]
Stored Maize DON-3G 70 NA HPLC/ESI-MS/MS 10 0.1–76 [39]
Stored Maize HYD FB1 70 NA HPLC/ESI-MS/MS 52.9 0.4–135 [39]
Stored Maize MON 70 NA HPLC/ESI-MS/MS 77.1 0.8–899 [39]
Maize 15-MAS 32 NA GC-MS 3.1 4 (mean) [129]
Maize T-2T 32 NA GC-MS 6.3 73–280 [129]
Maize ZEN-14G 136 SPE (C18), MultiSep LC-MS/MS 9 21 (mean) [88]
Maize α-ZEL 136 SPE (C18), MultiSep LC-MS/MS 1 20 (mean) [88]
Maize β-ZEL 136 SPE (C18), MultiSep LC-MS/MS 2 20 (mean) [88]
Sorghum 15-ADON 110 SPE (C18), MultiSep LC-MS/MS 2 39 (mean) [88]
Sorghum DON-3G 110 SPE (C18), MultiSep LC-MS/MS 23 24 (mean) [88]
Sorghum ZEN-14G 110 SPE (C18), MultiSep LC-MS/MS 3 19 (mean) [88]
Sorghum α-ZEL 110 SPE (C18), MultiSep LC-MS/MS 3 33 (mean) [88]
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Table 4. Cont.
Country Sample Type Mycotoxin Type No of Samples Sample Preparation Technique % Positive Range (µg/kg) Reference
Sorghum β-ZEL 110 SPE (C18), MultiSep LC-MS/MS 1 21 (mean) [88]
Millet 15-ADON 87 SPE (C18), MultiSep LC-MS/MS 1 11 (mean) [88]
Millet ZEN-14G 87 SPE (C18), MultiSep LC-MS/MS 6 23 (mean) [88]
Millet β-ZEL 87 SPE (C18), MultiSep LC-MS/MS 1 39 (mean) [88]
Ogi 15-ADON 30 SPE (C18), MultiSep LC-MS/MS 3 60 (mean) [88]
Ogi DON-3G 30 SPE (C18), MultiSep LC-MS/MS 17 30 (mean) [88]
Ogi ZEN-14G 30 SPE (C18), MultiSep LC-MS/MS 3 31 (mean) [88]
Ogi α-ZEL 30 SPE (C18), MultiSep LC-MS/MS 7 20 (mean) [88]
Ogi β-ZEL 30 SPE (C18), MultiSep LC-MS/MS 10 19 (mean) [88]
Peanut cake BEA 29 NA HPLC/ESI-MS/MS 100 0.05–3.4 [175]
Poultry feed BEA 58 NA HPLC/ESI-MS/MS 100 3–39 [90]
Poultry feed ENN A 58 NA HPLC/ESI-MS/MS 74 0.3–15 [90]
Poultry feed ENN A1 58 NA HPLC/ESI-MS/MS 79 0.5–101 [90]
Poultry feed ENN B 58 NA HPLC/ESI-MS/MS 91 0.1–141 [90]
Poultry feed ENN B1 58 NA HPLC/ESI-MS/MS 81 1–182 [90]
Poultry feed ENN B2 58 NA HPLC/ESI-MS/MS 22 1–8 [90]
Poultry feed ENN B3 58 NA HPLC/ESI-MS/MS 2 0.007 (mean) [90]
Poultry feed HYD FB1 58 NA HPLC/ESI-MS/MS 16 2–11 [90]
Zimbabwe Maize 15-ADON 95 SPE (amino) LC-MS/MS 4 nd–105 [100]
Burkina Faso, others = 30 (sorghum—7, millet—3, rice—3, sesame—2, wheat—1, infant food formulations—3, mixed cuscus—3, cornflakes—2, cookies—2 and dried fruits–4);
Mozambique, others = 7 (millet—2, soy—3, waste product from feed production—2); nd = not detected; NA = not applicable; LOQ = limit of quantification; BEA = beauvericin;
ENN = enniatin; MON = moniliformin; FUS = fusaproliferin; 15-MAS = 15-monoacetoxyscirpenol; FA = fusaric acid; 3-ADON = 3-acetyldeoxynivalenol; 15-ADON =
15-acetyldeoxynivalenol; α-ZEL = α-zearalenol; β-ZEL = β-zearalenol; DON-3G = deoxynivalenol-3-glucoside; HYD FB1 = Hydrolysed FB1; ZEN-4S = zearalenone-4-sulfate;
T-2T = T2 Tetraol; SPE = solid phase extraction; GC-MS = gas chromatography/mass spectrometry; HPLC/ESI-MS/MS = liquid chromatography/electrospray ionization tandem mass
spectrometry; LC-MS/MS = liquid chromatography-tandem mass spectrometry.
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While there are evidences of the occurrence of modified mycotoxins in food and feed products, it is
presently impossible to establish regulations that protect consumers because of a lack of exposure and
toxicological data. Studies on this subject have been fragmented and hence unable to make quantum
leaps in filling the voids of unanswered questions. This necessitates an urgent need for more research
on the occurrence and the potential health effect of modified mycotoxins, as well as understanding the
behavior of modified mycotoxins during food processing. In our view, standardization of experimental
protocols, and clinical testing across laboratory and regions, is critical and timely. More research
efforts should be geared toward the development of reference standards for modified mycotoxins.
This will offer a platform for easy detection and quantification of modified mycotoxins in food and
food products across the globe.
3. Mitigation Strategies of Fusarium Mycotoxins during Processing
Over the years, the scientific community has proposed good agricultural practices (GAP), followed
by implementation of good manufacturing practices (GMP), and hazard analysis and critical control
points (HACCP) during food processing as a strategic measure in addressing the problems posed by
fungi and mycotoxins in the food system. Food processing may be physical (cleaning and milling
processes, physical adsorption, and thermal processes), chemical (use of ammonia, calcium hydroxide,
and sulfur containing compounds) or biological (malting, brewing, and fermentation). The degree
of reduction in mycotoxin concentrations in food crops and feeds by processing is dependent on the
matrix type, the mycotoxin, as well as the processing method, and different conditions employed.
Besides studying the effect of processing on mycotoxins, it is important to be aware of the possibility
of free mycotoxins co-occurring with their modified forms, or the free mycotoxins being modified and
fragmented into other forms during food processing, which may not be easily detected by routine
methods. A lack of awareness of these mitigation processes have prevented SSA from progressively
reducing mycotoxins in foods and feeds. Creating awareness on the effect of implementation of GAP,
GMP, and HACCP in the control of toxic metabolites in the food system will be ideal to some extent in
reducing the risk of mycotoxins exposure in both the rural and urban communities in SSA.
3.1. Cleaning and Milling
Cleaning and sorting are considered to be the first step of physical decontamination.
These techniques are regarded as superior methods because they pose no risk of producing degradable
products which subsequently may be toxic [176]. These methods are dated back as old as the beginning
of mankind. Several studies have reported the efficiency of physical decontamination methods such
as sorting, washing, dehulling, and removal of visible moldy and floating kernels in the reduction of
different types of mycotoxins in foods irrespective of the grain type [91,177–183]. Reduction between
26% and 69% of total FB in maize was observed by Sydenham et al. [179] as a result of cleaning, prior
to further processing. A 32% reduction in FB levels in maize in an industrial mill was also reported
by Scudamore and Patel [184]. The same trend was observed by Van der Westhuizen et al. [182],
who recorded a reduction range of 27%–93% of FB after sorting contaminated maize. Furthermore,
Pascale et al. [183] and Scudamore and Patel [185] observed a reduction of T-2 (62%) and HT-2
(53%), and DON (50%) in wheat grains after cleaning. The reduction recorded by these authors
may be ascribed to the fact that mycotoxins are often concentrated in dust and broken kernels
because of their susceptibility to fungal infection and subsequent mycotoxin production. Thus,
the percentage of mycotoxin reduction by cleaning and sorting of grains is determined by the
physical condition of the grains, as well as the type and effectiveness of the cleaning method.
In addition, milling plays a potential role in the reduction of Fusarium mycotoxins in grains. However,
the problem often encountered is the differential toxicity of the fractions resulting from grain separation.
Lee et al. [186], Dexter et al. [187], and Lancova et al. [188] registered the reduction of DON during
milling of wheat. This was in agreement with the study of Tibola et al. [189], who reported a higher
deposition of Fusarium mycotoxins in wheat bran after milling. A similar trend was observed with
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respect to emerging Fusarium mycotoxins. A reduction of 71% and 79% of ENN B and ENN B1 in wheat
flour, respectively, was recorded by Vaclavikova et al. [190] as a result of milling, with the highest
concentrations of ENN B and ENN B1 being detected in the bran and shorts. Moreover, similar results
were also reported regarding distribution of modified mycotoxins in cereals after milling [189,191,192].
The study on the fractionation of DON and DON-3G in milling fractions showed a similar trend
with white flours containing approximately 60% of the content in unprocessed wheat grains [191].
The reduction reported by these authors is attributed to the fact that, during dry milling, the highest
amounts of mycotoxins are concentrated in the fractions of the commodity (bran) that are less likely to
be used for food production, though these higher contaminated fractions mostly end up as animal feed.
Furthermore, wet milling of maize has shown to result in the reduction of mycotoxins. Mycotoxins
may dissolve into the steep water or be distributed among the by-products while the starch remains
relatively free from mycotoxins [193–195].
3.2. Thermal Treatment
Several other methods such as thermal treatment used in food processing have been studied to
understand its effects on mycotoxins. Mycotoxins are generally heat stable and as such are not easily
destroyed during most normal cooking processes [196,197]. However, at very high temperatures,
reduction has been reported to occur although this may be as a result of reactions resulting in the
formation of products with altered chemical structures. Ryu et al. [198] proved the effectiveness of
thermal treatment (extrusion cooking) on the reduction between 66% and 83% of ZEN at temperature
ranging from 120 ◦C to 160 ◦C. Scott and Lawrence [199] also reported 60%–100% reduction of FB
when heating dry and moist corn meal at 190 ◦C (60 min) and 220 ◦C (25 min) respectively. In addition,
Shephard et al. [200], in their study using a traditional South African method for production of maize
porridge, observed about 23% reduction in FB concentration. Notwithstanding the FB reduction
reported during thermal processing, it is important to state the frequent occurrence of bound FB
in thermally treated foods because of the binding of FB with matrix constituents through covalent
interaction at high temperatures via a Maillard-type reaction [201]. This is evidenced in the studies
available on the effect of thermal treatment on FB, which indicated that the largest reduction of FB
occurs at a temperature of 160 ◦C or more in the presence of glucose [202]. The main products were
N-carboxymethyl FB and N-deoxyfructosyl FB although upon alkali treatment, a hydrolyzed form
may be formed by the cleavage of both carballylic moieties [202]. These bound FBs are not detectable
by the basic routine analytical methods, which may thus explain the reduction reported.
In the case of TH such as DON, there have been lots of contradicting reports by different
authors on the effect of thermal processing. While Bergamini et al. [203], Kostelanska et al. [191],
Numanoglu et al. [204], and Vidal et al. [205] reported a reduction in DON content in bread; Lancova
et al. [188] and Scudamore et al. [206] recorded no effect in DON concentration by thermal processes.
This conflicting disparity may be attributed to varying baking temperatures, baking procedures,
and ingredients used. Furthermore, the analytical methods used and experimental conditions
may have contributed to the variation in the trends observed by these scientists. Interestingly,
De Angelis et al. [207] documented an approximately 18% higher level of DON in bread when
compared to the original flour, which is in line with the study of Young et al. [208]. The increase
may be explained by the release of DON from their modified forms of DON-3G. This phenomenon
corresponded with the significant drop in DON-3G levels in bread, and may be due to the activities
of yeast during fermentation. In contrast, Vidal et al. [205] reported an increase in DON-3G during
baking. Moreover, the same authors investigated the effect of bread baking on T-2, HT-2, and their
glucoside conjugates and observed a reduction in the concentration of T-2 (range: 63%–74%) in bread
as compared with the original flour, while HT-2 levels appeared to be less affected [207]. A reduction of
T-2 may be ascribed to the partial conversion of T-2 to HT-2 during yeast fermentation operated by the
carboxylesterase naturally present in cereal-based products and/or partial degradation of T-2 due to
thermal treatment. In the case of T-2 glucoside (T-2G) and HT-2 glucoside (HT-2G), the same trend was
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recorded in HT-2G, while a reverse behavior was found for T-2G. These results agreed with the report
of Humpf and Voss [202] on the possible formation of unknown biologically active compounds or the
reversible binding of the toxin to sugars or proteins in the food/feed matrix during heat treatment.
3.3. Fermentation
Another universal biological food processing method is fermentation. In SSA, fermentation is
one of the most technologically appropriate methods for food processing because of its affordability
and suitability for the production of staple foods in rural and urban regions. Although fermentation
offers many advantages such as food preservation, enhanced sensory qualities, increased nutritional
value and variety of food type, reduced anti-nutritional compounds, improved functional properties,
and food safety, the living cells and enzymes used during this process may lead to the liberation
or transformation of mycotoxins into modified mycotoxins. Furthermore, Fusarium fungi when
present during fermentation, are still capable of growing and synthesizing mycotoxins. Information
on the effect of fermentation on Fusarium mycotoxins, especially using the African traditional
fermentation methods, is limited. Diverse results have been reported by different authors on the
effect of fermentation on mycotoxins (especially DON) during bread making. While some studies
recorded a mean reduction of DON in fermented dough [209–211], others reported stability [212] and
an increase in DON concentration during fermentation [203,205,208], although the increase observed
by Vidal et al. [205] was a combined effect of kneading, fermentation, and proofing. These conflicting
reports could be a result of several factors such as differences in technology, process temperature, and
initial concentration of the mycotoxins. Interestingly, the possible explanation of the increase in DON
concentration as reported by the latter authors may be a result of the enzymatic release of bound forms
of DON occurring in the raw materials. Kostelanska et al. [191] reported an increase of up to 145%
in DON-3G in the fermented dough when a bakery improver’s enzymes (16% of protease, 39% of
xylanase) were added. A similar report on the increase in DON (3.5%) after fermentation was observed
in wheat germ-enriched bread [213].
A study on the effect of fermentation on mycotoxins during local processing of Nepalese
traditional beer using experimentally contaminated maize showed stability of FB1 throughout
the fermentation process, while a 50% reduction in DON was recorded [214]. In contrast,
Bothast et al. [215] observed a low reduction of FB1 during the fermentation of naturally contaminated
maize for ethanol production. Ezekiel et al. [216] reported high-percentage (99%, 100%, 98%, 98%,
and 76%) reductions of DON, FB, fusaproliferin (FP), MON, and ZEN in fermented Nigerian
cereal-based beverages (kunu-zaki and pito), respectively. However, their result showed a much higher
reduction in maize-based beverage (kunu-zaki), when compared to sorghum-based beverage (pito)
because the raw maize was more contaminated than the raw sorghum. This proves that the degree of
the reduction of mycotoxins in foods or feeds is dependent on the initial mycotoxin concentrations.
In a recent study on the effect of malting process on Fusarium mycotoxins, the authors observed a
similar behavior of DON, 3-ADON, and 15-ADON throughout the malting process, while steeping
reduced the concentration of DON, 3-ADON, and 15-ADON between 15% and 49% of the initial level
independent of the cultivar and inoculation type [217,218]. In contrast, Kostelanska et al. [219] and
Habler et al. [218] observed an opposite effect on DON-3G after germination, apparently because of
the induction of glycosylation of DON by DON-glycosyl-transferase enzyme during germination [217].
In view of the conflicting data reported by different studies on the effect of processing methods on
mycotoxins, there is a need for further studies to harmonize and fully understand the behavior of
mycotoxins during food processing.
4. Future Perspectives for Sub-Saharan Africa
The economic and health hazards of mycotoxin contamination in crops and food products present
a huge challenge, especially in SSA, where there is limited data to ascertain the degree of harm caused
by these toxins. Tackling this problem needs a multi-factorial approach. A workable strategy would be
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the systematic development of centers of research expertise, and building research capacities aimed
at establishing a database on health-related risks caused by mycotoxins. Growing the interest of
the African scientific community towards increasing the research output in the region is imperative.
To this end, building a human resource capacity on mycotoxicology is a good starting point. National
and regional hubs of excellence can be used as a platform. This will ensure a coordinated response
approach, while postgraduate training using state-of-the-art infrastructure will ensure sustainability.
The present analytical methods in SSA may not provide accurate measurements of total contamination
in food crops and products, and may underestimate the actual levels. The lack of data precision and
reproducibility is creating a significant bottleneck to progress. Recent advances in chromatographic
techniques such as high-performance liquid chromatography (HPLC), liquid chromatography-mass
spectrometry (LC-MS), and high-resolution mass spectrometry (HR-MS) provide more choices and
options to improve analytical performance. However, this is not the case in SSA as these instruments
are rarely available, and when available, there is difficulty in maintaining and servicing due to epileptic
power voltage, unskilled manpower for instrumentation maintenance, and absence of technical outlets
of the manufacturing companies in the region. The establishment of technical offices within the
national and regional hubs as proposed above will cushion these effects. In addition, developing the
technical expertise of African nationals with respect to maintenance and management of these sensitive
analytical instruments will be more pro-active, and in the long run more beneficial to SSA. In the midst
of these challenges, the development of simple, precise, and low-cost diagnostic tests such as ELISA
and lateral flow immunoassay (LFIA) can foster better mycotoxin monitoring in SSA. Governments
within the region need to ensure a stability in policy, economics, and political environment to guarantee
investment. An accelerated human capacity and infrastructural growth in mycotoxins research is
proposed. The systemic institutional weakness of existing food regulatory agencies in SSA can be
circumvented through the stakeholders’ advocacy and regional partnerships. The establishment of a
mycotoxin community of practice as well as the strengthening of mycotoxicology scientific meetings
represent a good starting point.
Another great challenge for the next decade is to mitigate the effect of climate change on crop
production with a focus on sustaining crop and animal production levels with reduced contamination.
A multi-pronged approach of using a combined expertise will be critical in sustaining a healthy food
intake most especially in SSA. Management strategies need to put into perspective the influence
of input control measures of mycotoxigenic pathogens, the influence of environmental phenomena,
the prevalence of non-symptomatic crops with toxin contamination, and the prevalence of quantitative
resistance crops to both pathogen infections and toxin production. Furthermore, concerted efforts are
required by farmers, post-harvest food specialists, breeders, agronomists, and technologists toward
precise and strategic management systems with respect to the diverse staple food systems in the region.
The technical institutional and policy intervention measures are non-existent in most countries
within SSA. Establishment of these frameworks with legal backup will help in tackling problems that
might arise in the context of screening the commodity value chain. We think there is no systemic
surveillance of Fusarium mycotoxin diversity in toxigenic fungi in SSA. Such studies have been
highly fragmentary. A regular surveillance survey in this regard will add value to already known
knowledge, while bringing to the fore a better understanding of the depth of problems inherent in SSA.
An understanding of the evolutionary dynamics of these toxins is mostly needed. Breeding
for field crop quantitative resistance is yet another option. Most often, field crop breeders are
biased towards yield and disease resistance. An integrated team of postharvest specialists and
mycotoxicologists should be part of the screening or phenotyping process of the breeder. Varietal
releases should incorporate some sort of quantitative resistance to toxigenic fungi. Looking beyond
the conventional breeding effort, genetic engineering can be exploited where specific genes of interest
can be integrated to mitigate or prevent toxigenic progression of most fungi. Biological control
measures using competitive exclusion principles in the various cropping systems can be exploited.
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This proved efficient in the control of pathogens [220] as exhibited by the use of atoxigenic strains of
Aspergillus flavus to control aflatoxin producing A. flavus [221].
5. Conclusions
Although there is wealth of information on Aspergillus mycotoxins, especially the aflatoxins
in SSA, the reverse remain the case with the Fusarium mycotoxins as revealed in this review.
The knowledge gap as regards Fusarium mycotoxin research in SSA is of concern because of the
frequent occurrence and co-occurrence of these toxins in staple food and food products. Few studies
conducted on the occurrence of the major Fusarium mycotoxins (FB, TH, and ZEN) in food and food
products in SSA revealed possible high levels of these toxins, in most cases exceeding the maximum
limit set by regulatory agencies. A recent concern is the occurrence of emerging and modified Fusarium
mycotoxins in food and feed commodities. Although the metabolic fate of modified mycotoxins still
remains a matter of scientific discourse, SSA must not be left behind. Existing reports on in vitro
and in vivo metabolic studies of modified mycotoxins prove that these toxins may be hydrolyzed to
the free toxins in the gastrointestinal tract, thereby indicating potential toxic relevance on the host
species. As such, there is need for constant and continuous monitoring of the occurrence of Fusarium
mycotoxins and their modified forms in food and feed commodities as some form of prevention as
food quality in SSA improves.
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Abbreviation
The following abbreviations are used in this manuscript:
3-ADON 3-acetyldeoxynivalenol
15-ADON 15-acetyldeoxynivalenol
15-MAS 15-monoacetoxyscirpenol
α-ZEL α-zearalenol
β-ZEL β-zearalenol
BEA beauvericin
CAC Codex Alimentarius Commission
DAS diacetoxyscirpenol
DOM de-epoxy deoxynivalenol
DON deoxynivalenol
DON-3G deoxynivalenol-3-glucoside
ELISA enzyme-linked immunosorbent assay
ENN enniatin
EU European Union
FA fusaric acid
FAO Food and Agriculture Organization
FB fumonisin
FP fusaproliferin
FX fusarenon X
FUS fusaproliferin
GC-MS gas chromatography/mass spectrometry
GAP good agricultural practices
GMP good manufacturing practices
HACCP hazard analysis and critical control points
HPLC high-performance liquid chromatography
HPLC/ESI-MS/MS liquid chromatography/electrospray ionization tandem mass spectrometry
HR-MS high-resolution mass spectrometry
HT2 HT-2 toxin
HT-2G HT-2 glucoside
HYD hydrolyzed FB1
IAC immunoaffinity column,
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IARC International Agency for Research on Cancer
LC-MS/MS liquid chromatography-tandem mass spectrometry
LFIA lateral flow immunoassay
LOQ limit of quantification
MON moniliformin
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
NA not applicable
nd not detected
NEO neosolaniol
NIV nivalenol
SAX strong anion exchange
SPE solid phase extraction
SSA sub-Saharan Africa
T2 T-2 toxin
T-2G T-2 glucoside
T-2T T2 tetraol
TH trichothecenes
TLC thin layer chromatography
UHPLC/TOFMS ultra-high performance liquid chromatography/time-of-flight mass spectrometry
ZEN zearalenone
ZEN-4S zearalenone-4-sulfate
ZEN-14G zearalenone-14-glucoside
ZEN-14S zearalenone-14-sulfate
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